Results 161 to 170 of about 4,062 (291)

Evidential and epistemic devices in English and Spanish medical, computing and legal scientific abstracts: A contrastive study

, 2014
This chapter explores the categories of evidentiality, i.e. the mode of knowing, and epistemic modality, i.e. judgements about truth, in a corpus of English and Spanish abstracts in the fields of medicine, computing and law written between 1998-2008 by ...
Alonso Almeida, Francisco
core  

Multiphasic Evidential Decision-Making Matrix (MedMax) for Intrahepatic Cholangiocarcinoma: A Single-Center Validation Study. [PDF]

Cancers (Basel)
Ramouz A, Adeliansedehi A, Chagervand BM, Sabetkish N, Goeppert B, Springfeld C, Khajeh E, Mehrabi A, Majlesara A.   +8 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Beyond Model Development in Healthcare AI: Post-Development Robustness, Post-Deployment Monitoring, and Lifecycle Governance-A Scoping Review of Reviews. [PDF]

Healthcare (Basel)
El Arab RA, Mustafa MH, Almagharbeh WT, Saleem NH, Al Abdulmohsen S, Boathab R, Bu Washl M.   +6 more
europepmc   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source

Cloudy with a chance of uncertainty: autoconversion rates forecasting via evidential regression from satellite data [PDF]

High-resolution simulations such as the ICOsahedral Non-hydrostatic Large-Eddy Model (ICON-LEM) can be used to understand the interactions among aerosols, clouds, and precipitation processes that currently represent the largest source of uncertainty ...
Rodrigues, Miguel RD, Quaas, Johannes, Novitasari, Maria Carolina   +2 more
core  

Uncertainty Calibration in Molecular Machine Learning: Comparing Evidential and Ensemble Approaches. [PDF]

Chemistry
Garain BC, Pinheiro M, Bispo MO, Barbatti M.   +3 more
europepmc   +1 more source

Evidentiality Strategies as Distinguishing Markers in Forensic Authorship Analysis [PDF]

Анали Филолошког факултета, 2019
openaire   +1 more source

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

Molecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel, Izabela Kubiak, Lena Rutkowska, Żaneta Kasprzyk, Łukasz Kępczyński, Michał Bednarek, Dariusz Sobieraj, Jacek Wilkosz, Piotr Kania, Adam Jędrzejczyk, Bogdan Kałużewski, Agnieszka Gach, Tadeusz Kałużewski   +12 more
wiley   +1 more source